Clinical Trial Update: Evaluation of Serum IL-7 as a Biomarker in Breast Cancer

View source ↗

Summary

A clinical trial is evaluating serum interleukin-7 as a biomarker in breast cancer. The study status is NOT_YET_RECRUITING.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Assiut University | Conditions: Breast Cancer | Status: NOT_YET_RECRUITING